Literature DB >> 1889308

Inhibitory effect of tachyplesin I on the proliferation of human immunodeficiency virus in vitro.

M Morimoto1, H Mori, T Otake, N Ueba, N Kunita, M Niwa, T Murakami, S Iwanaga.   

Abstract

An antimicrobial peptide, tachyplesin I, isolated from hemocytes of the Japanese horseshoe crab (Tachypleus tridentatus) was examined for its inhibitory effects on human immunodeficiency virus (HIV) infection in vitro. At a concentration of 7.5 micrograms/ml, tachyplesin I suppressed the development of cytopathic effects (CPE) by more than 70% in MT-4 cells infected with HIV (lymphadenopathy-associated virus). This inhibitory effect was observed only when the drug was added during the adsorption period of the virus to the cells. In cocultures of MOLT-4 and persistently HIV-infected cells (MOLT-4/HIV), tachyplesin I at the same concentration completely inhibited multinucleated giant cell formation. Infectivity of HIV was reduced by 10(-2.5) in medium free from fetal calf serum containing tachyplesin I at a concentration of 200 micrograms/ml. Tachyplesin I did not show any inhibitory effect on reverse transcriptase activity of HIV at concentrations of 9-80 micrograms/ml at which tachyplesin I inhibited HIV infection. These results suggest that the anti-HIV action of tachyplesin I was due to the inhibition of virus adsorption.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1889308     DOI: 10.1159/000238855

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  18 in total

Review 1.  Antimicrobial peptides from marine invertebrates.

Authors:  J Andy Tincu; Steven W Taylor
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 2.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

Review 3.  Peptide antimicrobial agents.

Authors:  Håvard Jenssen; Pamela Hamill; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

Review 4.  Studies on anticancer activities of antimicrobial peptides.

Authors:  David W Hoskin; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2007-11-22

Review 5.  Discoveries and developments of CXCR4-targeted HIV-1 entry inhibitors.

Authors:  Chaozai Zhang; Ruohan Zhu; Qizhi Cao; Xiaohong Yang; Ziwei Huang; Jing An
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-04

6.  Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.

Authors:  H Nakashima; M Masuda; T Murakami; Y Koyanagi; A Matsumoto; N Fujii; N Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

7.  A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses.

Authors:  Christopher J Sample; Kathryn E Hudak; Brice E Barefoot; Matthew D Koci; Moses S Wanyonyi; Soman Abraham; Herman F Staats; Elizabeth A Ramsburg
Journal:  Peptides       Date:  2013-07-26       Impact factor: 3.750

Review 8.  The intricate role of CXCR4 in cancer.

Authors:  Samit Chatterjee; Babak Behnam Azad; Sridhar Nimmagadda
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

9.  Marine natural products: a way to new drugs.

Authors:  V A Stonik
Journal:  Acta Naturae       Date:  2009-07       Impact factor: 1.845

10.  Carrageenan is a potent inhibitor of papillomavirus infection.

Authors:  Christopher B Buck; Cynthia D Thompson; Jeffrey N Roberts; Martin Müller; Douglas R Lowy; John T Schiller
Journal:  PLoS Pathog       Date:  2006-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.